MeeDoc provides a CE-certified telemedicine platform that lets users connect with doctors via chat or video call to receive healthcare consultations and prescriptions. The platform is HIPAA- and FDA-compliant and is available on iOS, Android and Windows. The company was founded in 2012 by doctors, designers and engineers. MeeDoc is headquartered in Helsinki and also has offices in New York and Berlin. In the reported round the company raised €3.5m in funding. Backers included XLHealth, a German venture capital investor specialized in digital health startups. Mikko Kiiskilä is CEO and co-founder of the company. Meedoc is a video conferencing app and service that lets patients connect with their doctor online for on-demand or pre-booked consultations. The company has registered as a CE‑certified medical device telemedicine platform, enabling it to be used for treatment across the European Union. Meedoc targets corporate customers, offering the service as part of employee healthcare plans to reduce time off work and provide early treatment for straightforward conditions. Doctors can prescribe medication after a Meedoc-facilitated diagnosis. The company charges €10 per month per employee for unlimited use and counts thousands of patients as users, including corporate customers such as KONE. Launched in Finland, Meedoc’s founders stress the importance of investors with healthcare expertise and regulatory connections to navigate Europe’s regulated market.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

May 2015